Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Hawn

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Drug Discovery Today. Disease Mechanisms|August 5, 2008
Tuberculosis Infection: Insight from ImmunogenomicsMatthew Arentz, Thomas R Hawn
Nature Immunology|May 25, 2021
Mitigating myopia in tuberculosisSarah J Dunstan, Thomas R Hawn
Clinical Immunology (Orlando, Fla.)|March 28, 2006
Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infectionsStuart E Turvey, Thomas R Hawn
The Journal of Clinical Investigation|August 2, 2021
Remodeling the matrix: doxycycline modulates tuberculosis immunopathologyJason D Simmons, Thomas R Hawn
Immunological Reviews|September 14, 2007
Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?William R Berrington, Thomas R Hawn
JAMA|September 5, 2013
Genetic variants associated with susceptibility to Helicobacter pyloriMark M Wurfel, Thomas R Hawn
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Human susceptibility to legionnaires' diseaseWilliam R Berrington, Thomas R Hawn
Clinical Science (London, England : 1979)|January 31, 2008
Toll-like receptor polymorphisms and susceptibility to human diseaseE Ann Misch, Thomas R Hawn
Expert Review of Anti-Infective Therapy|July 30, 2008
Toll-like receptors: their roles in bacterial recognition and respiratory infectionsApril Kaur Randhawa, Thomas R Hawn
Frontiers in Microbiology|February 22, 2020
Clinical Development of New TB Vaccines: Recent Advances and Next StepsMark Hatherill, Richard G White, Thomas R Hawn
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Drug Discovery Today. Disease Mechanisms|August 5, 2008
Tuberculosis Infection: Insight from ImmunogenomicsMatthew Arentz, Thomas R Hawn
Nature Immunology|May 25, 2021
Mitigating myopia in tuberculosisSarah J Dunstan, Thomas R Hawn
Clinical Immunology (Orlando, Fla.)|March 28, 2006
Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infectionsStuart E Turvey, Thomas R Hawn
The Journal of Clinical Investigation|August 2, 2021
Remodeling the matrix: doxycycline modulates tuberculosis immunopathologyJason D Simmons, Thomas R Hawn
Immunological Reviews|September 14, 2007
Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?William R Berrington, Thomas R Hawn
JAMA|September 5, 2013
Genetic variants associated with susceptibility to Helicobacter pyloriMark M Wurfel, Thomas R Hawn
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Human susceptibility to legionnaires' diseaseWilliam R Berrington, Thomas R Hawn
Clinical Science (London, England : 1979)|January 31, 2008
Toll-like receptor polymorphisms and susceptibility to human diseaseE Ann Misch, Thomas R Hawn
Expert Review of Anti-Infective Therapy|July 30, 2008
Toll-like receptors: their roles in bacterial recognition and respiratory infectionsApril Kaur Randhawa, Thomas R Hawn
Frontiers in Microbiology|February 22, 2020
Clinical Development of New TB Vaccines: Recent Advances and Next StepsMark Hatherill, Richard G White, Thomas R Hawn
Pageof 15